ADRENAVERSE Trademark

Trademark Overview


On Monday, October 30, 2023, a trademark application was filed for ADRENAVERSE with the United States Patent and Trademark Office. The USPTO has given the ADRENAVERSE trademark a serial number of 98247227. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by Aquestive Therapeutics, Inc.. The ADRENAVERSE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Technologies in the nature of pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of a wide-range of conditions, namely, anaphylaxis, asthma, and allergic reactions; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery platform technology, namely, drug delivery agents consisting of prodrugs of epinephrine that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents

Development of pharmaceutical preparations and medicines; Technology research in the field of pharmaceutical preparations and drug delivery agents; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations
adrenaverse

General Information


Serial Number98247227
Word MarkADRENAVERSE
Filing DateMonday, October 30, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesTechnologies in the nature of pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of a wide-range of conditions, namely, anaphylaxis, asthma, and allergic reactions; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery platform technology, namely, drug delivery agents consisting of prodrugs of epinephrine that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Technology research in the field of pharmaceutical preparations and drug delivery agents; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAquestive Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Party NameAquestive Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events


Event DateEvent Description
Thursday, November 2, 2023NEW APPLICATION ENTERED
Wednesday, November 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 1, 2024ASSIGNED TO EXAMINER
Monday, February 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024SOU EXTENSION 1 FILED
Wednesday, October 16, 2024SOU EXTENSION 1 GRANTED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED